These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15164607

  • 1. [Tumor markers of urinary tract carcinoma].
    Kikuchi H.
    Rinsho Byori; 2004 Apr; 52(4):371-80. PubMed ID: 15164607
    [Abstract] [Full Text] [Related]

  • 2. [Urinary tumor marker for urothelial cancer].
    Ohtani M, Iwasaki A, Shiraiwa H.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of serum markers for prostate cancer.
    Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [Abstract] [Full Text] [Related]

  • 4. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD, Rittenhouse HG.
    Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer.
    Karazanashvili G, Abrahamsson PA.
    J Urol; 2003 Feb; 169(2):445-57. PubMed ID: 12544286
    [Abstract] [Full Text] [Related]

  • 6. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C, Jung K, Lein M, Diamandis EP.
    Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
    [Abstract] [Full Text] [Related]

  • 7. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)].
    Tsuchiya N, Ohyama C, Habuchi T.
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):275-80. PubMed ID: 15751649
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies].
    Setoguchi C, Matsumoto K, Samori T, Kimura E, Harukaze S.
    Rinsho Byori; 1998 Jan; 46(1):79-82. PubMed ID: 9492543
    [Abstract] [Full Text] [Related]

  • 12. The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.
    Sardana G, Diamandis EP.
    Clin Biochem; 2009 Sep; 42(13-14):1483-6. PubMed ID: 19560453
    [Abstract] [Full Text] [Related]

  • 13. New markers and multivariate models for prostate cancer detection.
    Stephan C, Rittenhouse H, Cammann H, Lein M, Schrader M, Deger S, Miller K, Jung K.
    Anticancer Res; 2009 Jul; 29(7):2589-600. PubMed ID: 19596933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH, Graefen M, Kattan MW, Huland H, Lilja H.
    Prostate; 2005 Apr 01; 63(1):13-8. PubMed ID: 15378521
    [Abstract] [Full Text] [Related]

  • 16. [The search for better markers for prostate cancer than prostate-specific antigen].
    Schenk-Braat EA, Bangma CH.
    Ned Tijdschr Geneeskd; 2006 Jun 10; 150(23):1286-90. PubMed ID: 16821452
    [Abstract] [Full Text] [Related]

  • 17. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP.
    Int J Urol; 2006 Mar 10; 13(3):238-43. PubMed ID: 16643616
    [Abstract] [Full Text] [Related]

  • 18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 10; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.